Joseph Merola

61PUBLICATIONS
198CO-AUTHORS
AllergyPharmacogenomicsClinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Oct 22, 2026
Lebrikizumab Provides Stable and Deep Long-Term Response with No/Minimal Fluctuations up to 3 Years in Patients with Moderate-to-Severe Atopic Dermatitis.

|Oct 11, 2026
Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies.

|Aug 12, 2026
Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.

|Jun 15, 2026
Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease.

|Mar 16, 2026
Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.

Laure Gossec, Laura C Coates, Robert B M Landewé

|Mar 03, 2026
Mapping malignant T-cell states and immune circuits in Sézary syndrome by single-cell analysis.

Beth A Childs, Eslam A Elghonaimy, Praveen Ramakrishnan Geethakumari

Pageof 11

Frequent Collaborators

20 joint publications

Philip J Mease

14 joint publications

Lourdes Maria Perez-Chada

14 joint publications

April W Armstrong

11 joint publications

Alice B Gottlieb